MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/jaha.121.021746

Медицинская библиотека · Journal of the American Heart Association · 2021

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy.

Ko Darae, Saleeba Connor, Sadiq Hammad, Crawford Sybil, Paul Tenes, Shi Qiming, Wang Ziyue, Benjamin Emelia J, Walkey Allan J, Lubitz Steven A, Kapoor Alok, McManus David

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Background Atrial fibrillation (AF) commonly occurs in the setting of acute conditions. We aimed to identify the acute conditions associated with secondary AF (AF precipitants) including pneumonia/sepsis, pneumothorax, respiratory failure, myocarditis, pericarditis, alcohol intoxication, thyrotoxicosis, cardiothoracic surgery, other surgery in patients with newly diagnosed AF and determine their association with subsequent oral anticoagulant use. Methods and Results We assembled a cohort of patients in the UMass Memorial Healthcare system with a new diagnosis of AF with and without AF precipitants. We used combinations of International Classification of Diseases, Tenth Revision (ICD-10) codes, Current Procedural Terminology codes, laboratory values, imaging reports, and physician notes including discharge summary texts to identify AF precipitants. We then manually reviewed the individual charts to validate presence of AF precipitants. The study sample consisted of 185 patients with and 172 patients without AF precipitants. Pneumonia/sepsis, myocardial infarction, respiratory failure, and cardiothoracic surgery were the most common precipitants identified. In multivariable analyses adjusting for age, sex, patient comorbidities, left atrial enlargement, left ventricular ejection fraction, and antiplatelet use, patients with AF precipitants were less likely to receive subsequent anticoagulation therapy at 30 days after the initial AF diagnosis (odds ratio, 0.31; 95% CI, 0.19-0.52). The association was persistent after excluding men with CHA2DS2-VASc score <2 and women with CHA2DS2-VASc score <3. Conclusions Our study highlights lower usage of oral anticoagulant in secondary AF in contemporary clinical practice.

Для цитирования: Ko Darae, Saleeba Connor, Sadiq Hammad, Crawford Sybil, Paul Tenes, Shi Qiming, Wang Ziyue, Benjamin Emelia J, Walkey Allan J, Lubitz Steven A, Kapoor Alok, McManus David. Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy.. Journal of the American Heart Association. 2021. DOI: 10.1161/jaha.121.021746.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.